 NLS Pharmaceutics Ltd NLSP shares are trading higher after the Company announced to present interim topline data from its Phase 2a trial evaluating its lead product candidate, Quilience Mazindol ER, for narcolepsy at World Sleep Congress 2022. Get the Inside Access Traders Are Using to Profit More and Win Bigger. 